vimarsana.com

Latest Breaking News On - Vicky xia - Page 1 : vimarsana.com

Biopharma In China The Emerging Global Force Of Domestic Suppliers

A major factor in the emerging domestic competition is the Chinese drug industry’s response to cost pressures being implemented, such as the.

COVID-19 Spurs Growth Of China s Domestic Bioprocessing Suppliers

COVID-19 Spurs Growth Of China s Domestic Bioprocessing Suppliers

CPhI survey: pharma leaders optimistic about the future

CPhI survey: pharma leaders optimistic about the future According to a recent survey of executives conducted by CPhI, COVID-19’s impact is driving manufacturing and CDMOs are fueling industry growth. CPhI has released a survey taking the post-pandemic temperature pharmaceutical leaders, gauging how they feel about the industry’s prospects in the immediate and medium-term future. The findings in the report (to be outlined in a May 20 session during the organization’s virtual CPhI Discover event) reveal companies and governmental bodies alike are keenly interested in increasing regional self-reliance, reducing system complexity, and more. Outsourcing-Pharma spoke about the survey, and notable CPhI Discover sessions worth a closer look, with Tara Dougal, head of content at Informa Markets.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.